CTS - CTS Corporation
34.55 0.00 (0.00%)
After hours: 4:31PM EDT
| Previous Close | 34.60 |
| Open | 34.50 |
| Bid | 24.95 x 900 |
| Ask | 35.50 x 4000 |
| Day's Range | 33.90 - 35.00 |
| 52 Week Range | 21.55 - 39.20 |
| Volume | 133,679 |
| Avg. Volume | 150,314 |
| Market Cap | 1.143B |
| Beta | 0.90 |
| PE Ratio (TTM) | 78.17 |
| EPS (TTM) | 0.44 |
| Earnings Date | Oct 26, 2017 - Oct 30, 2017 |
| Forward Dividend & Yield | 0.16 (0.45%) |
| Ex-Dividend Date | 2018-06-21 |
| 1y Target Est | 37.00 |
- Thomson Reuters StreetEvents•22 days ago
Edited Transcript of CTS earnings conference call or presentation 26-Jul-18 3:00pm GMT
Q2 2018 CTS Corp Earnings Call
- Associated Press•22 days ago
CTS: 2Q Earnings Snapshot
On a per-share basis, the Lisle, Illinois-based company said it had profit of 21 cents. Earnings, adjusted for non-recurring costs and pretax expenses, were 39 cents per share. The electronics manufacturer ...
- GlobeNewswire•22 days ago
CTS Announces Second Quarter 2018 Results
LISLE, Ill., July 26, 2018-- CTS Corporation today announced second quarter 2018 results. Sales were $118.0 million, up 11.7% year-over-year, with organic growth at 10.9%. Sales to transportation customers ...
- PR Newswire•last month
Kodiak Sciences Appoints Bassil I. Dahiyat, Ph.D. Robert A. Profusek, J.D. and Richard S. Levy, M.D. to its Board of Directors
PALO ALTO, Calif., July 18, 2018 /PRNewswire/ -- Kodiak Sciences Inc., a clinical stage biopharmaceutical company specializing in novel therapeutics to treat high prevalence ophthalmic diseases, today announced the appointments of Bassil I. Dahiyat, Ph.D., Robert A. Profusek, J.D., and Richard S. Levy, M.D. to its Board of Directors. Dr. Dahiyat is the co-founder of Xencor (XNCR), a biopharmaceutical company, and has been its President and Chief Executive Officer since the Company's incorporation in August 1997. Dr. Dahiyat is a co-inventor of Xencor's breakthrough XmAb® antibody engineering technology. He has led Xencor in raising over $700 million in public and private financing, creating a diverse portfolio of monoclonal antibody clinical programs for the treatment of life-threatening and debilitating diseases and establishing alliances with leading biopharmaceutical companies that generated over $200 million in upfront payments. Dr. Dahiyat holds a Ph.D. in Chemistry from Caltech and B.S. and M.S.E. degrees in Biomedical Engineering from the Johns Hopkins University. He has co-authored numerous scientific papers in the fields of protein design and drug delivery, is an inventor of 33 US and numerous foreign patents and has received scientific awards from the American Chemical Society, the Controlled Release Society, the Protein Society and Caltech.
- GlobeNewswire•last month
CTS Corporation Announces Dates for Second Quarter 2018 Earnings Release and Conference Call
LISLE, Ill., July 12, 2018-- CTS Corporation will release earnings for the second quarter 2018 at approximately 8:00 a.m. on Thursday, July 26, 2018.. A conference call to discuss second quarter results ...
- Reuters•2 months ago
BRIEF-CTS International Logistics Signs Strategic Framework Agreement With JD Logistics' Trading Firm
June 28 (Reuters) - CTS International Logistics Corp Ltd : * SAYS IT SIGNS STRATEGIC COOPERATION FRAMEWORK AGREEMENT WITH JD LOGISTICS' TRADING FIRM Source text in Chinese: https://bit.ly/2ICIV9A Further ...
- GlobeNewswire•2 months ago
Factors of Influence in 2018, Key Indicators and Opportunity within Immune Pharmaceuticals, Wells Fargo, Anadarko Petroleum, CTS, REGENXBIO, and TripAdvisor — New Research Emphasizes Economic Growth
NEW YORK, June 25, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Immune ...
- Simply Wall St.•2 months ago
Is CTS Corporation’s (NYSE:CTS) Balance Sheet Strong Enough To Weather A Storm?
Investors are always looking for growth in small-cap stocks like CTS Corporation (NYSE:CTS), with a market cap of US$1.15b. However, an important fact which most ignore is: how financially healthyRead More...
- Reuters•2 months ago
BRIEF-CTS International Logistics To Set Up In SPV With Partners To Invest In Jingdong Express
June 22 (Reuters) - CTS International Logistics Corp Ltd : * SAYS UNIT PLANS TO INVEST $41.6 MILLION TO SET UP SPV WITH YULONGHE CAPITAL MANAGEMENT, HANJIANG INVESTMENT * SAYS THE SPV WILL INVEST $90 MILLION ...
- Simply Wall St.•2 months ago
Is City Service SE’s (WSE:CTS) Balance Sheet Strong Enough To Weather A Storm?
While small-cap stocks, such as City Service SE (WSE:CTS) with its market cap of ZŁ331.91M, are popular for their explosive growth, investors should also be aware of their balance sheetRead More...
- Simply Wall St.•3 months ago
Should You Be Tempted To Buy City Service SE (WSE:CTS) Because Of Its PE Ratio?
City Service SE (WSE:CTS) trades with a trailing P/E of 13.2x, which is lower than the industry average of 13.3x. While this makes CTS appear like a great stock toRead More...
- Simply Wall St.•3 months ago
Did City Service SE (WSE:CTS) Create Value For Shareholders?
With an ROE of 11.05%, City Service SE (WSE:CTS) outpaced its own industry which delivered a less exciting 10.48% over the past year. While the impressive ratio tells us thatRead More...
- Zacks Small Cap Research•4 months ago
CTS: Organic growth of nearly 11% Y/Y pushed revenue and earnings to new highs. We are increasing our target price to $32 a share.
CTS Corporation's (CTS) first quarter 2018 results were above our estimates due mainly to above average revenue growth of 10.8% organic plus $2.6 million from the Noliac acquisition. Due to the need to preserve expert knowledge from many years of production in Indiana CST spent an above average amount of money in transferring production to Illinois. This had a negative impact on gross margins so gross profit was close to our estimate.
- Thomson Reuters StreetEvents•4 months ago
Edited Transcript of CTS earnings conference call or presentation 26-Apr-18 3:00pm GMT
Q1 2018 CTS Corp Earnings Call
- Associated Press•4 months ago
CTS: 1Q Earnings Snapshot
The Lisle, Illinois-based company said it had net income of 34 cents per share. The electronics manufacturer posted revenue of $113.5 million in the period. CTS expects full-year earnings in the range ...
- ACCESSWIRE•4 months ago
CTS Corporation to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / April 26, 2018 / CTS Corporation (NYSE: CTS ) will be discussing their earnings results in their Q1 Earnings Call to be held on April 26, 2018 at 11:00:00 AM Eastern Time. To ...
- Reuters•5 months ago
AMD to release patches to fix some chip flaws uncovered by CTS Labs
Israeli cyber security research firm CTS Labs in its report said the attackers would need administrative access to exploit the vulnerabilities. CTS executives had told Reuters that they shared their findings with some clients who pay the firm for proprietary research on vulnerabilities in computer hardware.
